MIRA
Mira Pharmaceuticals, Inc.Company with tickers: MIRA
CIK
1904286
CUSIP
60458C104
Shares Outstanding
42,022,087
13F Activity (30d)
12 filings
12 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-08 | 2026-06-02 | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-05-27 | 2026-05-21 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-13 | — | |
| 8-K | 2026-05-13 | 2026-05-12 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-23 | — | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-02-02 | — | |
| 8-K | 2025-12-22 | 2025-12-17 | |
| 8-K | 2025-12-05 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-10-23 | — | |
| 8-K | 2025-10-16 | — | |
| 8-K | 2025-10-15 | — | |
| 8-K | 2025-09-30 | 2025-09-29 | |
| 8-K | 2025-09-22 | — | |
| 8-K | 2025-09-15 | — | |
| 8-K | 2025-09-11 | — | |
| 8-K | 2025-08-19 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-07-28 | — | |
| 8-K | 2025-07-10 | — | |
| 8-K | 2025-07-08 | 2025-07-03 | |
| 8-K | 2025-07-02 | — | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-24 | — | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-05-21 | 2025-05-15 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-05-06 | — | |
| 8-K | 2025-04-23 | — | |
| 10-K/A | 2025-04-17 | 2024-12-31 | |
| 8-K | 2025-04-16 | — | |
| 10-K/A | 2025-04-15 | 2024-12-31 | |
| 8-K | 2025-04-11 | 2025-04-08 | |
| 8-K | 2025-04-01 | — | |
| 10-K | 2025-03-28 | 2024-12-31 | |
| 8-K | 2025-03-24 | 2025-03-19 | |
| 8-K | 2025-03-13 | — | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2024-12-20 | 2024-12-16 | |
| 8-K | 2024-12-19 | — | |
| 8-K | 2024-12-10 | — | |
| 8-K | 2024-11-21 | 2024-11-18 |
Showing 1–50 of 78 filings